Log in to save to my catalogue

Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2

Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ce6ee2a5d014a70b42089eb87d344e5

Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2

About this item

Full title

Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2

Publisher

Basel: MDPI AG

Journal title

Biomolecules (Basel, Switzerland), 2021-07, Vol.11 (8), p.1114

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

SARS-CoV-2 infection of host cells is driven by binding of the SARS-CoV-2 spike-(S)-protein to lung type II pneumocytes, followed by virus replication. Surfactant protein SP-D, member of the front-line immune defense of the lungs, binds glycosylated structures on invading pathogens such as viruses to induce their clearance from the lungs. The objec...

Alternative Titles

Full title

Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1ce6ee2a5d014a70b42089eb87d344e5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ce6ee2a5d014a70b42089eb87d344e5

Other Identifiers

ISSN

2218-273X

E-ISSN

2218-273X

DOI

10.3390/biom11081114

How to access this item